261
Participants
Start Date
March 4, 2020
Primary Completion Date
August 4, 2023
Study Completion Date
August 5, 2024
AeroFact
Aerosolized SF-RI 1
nCPAP
nCPAP (nasal continuous positive airway pressure) alone
Mount Sinai Kravis Children's Hospital, New York
Columbia University Medical Center/New York Presbyterian Hospital, New York
NY Presbyterian Morgan Stanley Children's Hospital-Columbia, New York
West Chester Medical Center-Maria Fareri Children's Hospital, Valhalla
Maimonides Hospital, Brooklyn
Holy Cross Hospital, Silver Spring
University of Maryland, Baltimore
University of Virginia, Charlottesville
Levine Children's Hospital, Charlotte
Northside Hospital Atlanta, Atlanta
University of Florida Health, Jacksonville
Wolfson Children's Hospital, Jacksonville
Advent Health, Orlando
Winnie Palmer Hospital, Orlando
South Miami Hospital, Miami
University of Mississippi, Jackson
University of Louisville, Louisville
Grant Hospital, Columbus
Hospital of South Bend, South Bend
Children's and Women's (C & W) Mott Hospital, Ann Arbor
Children's Health Care d/b/a Children's Minnesota, Minneapolis
University of Minnesota Masonic Children's Hospital, Minneapolis
Mayo Clinic, Rochester
University of Illinois, Chicago
University of Arkansas for Medical Sciences, Little Rock
Texas Health-Methodist Harris, Fort Worth
Women's Hospital of Texas, Houston
Children's Hospital of San Antonio (CHofSA), San Antonio
Methodist Children's Hospital, San Antonio
North Central Baptist Hospital, San Antonio
University of Colorado, Aurora
Children's Hospital Orange County, Orange
Alta Bates Summit, Berkeley
University of Washington, Seattle
Barbara Bush Medical Center, Portland
Beth Israel Deaconess Medical Center, Boston
Dartmouth Hitchcock Medical Center, Lebanon
IWK Hospital, Halifax
The Ottawa Hospital, Ottawa
Mt. Sinai Hospital, Toronto
CHU de Québec-Université Laval, Québec
Lead Sponsor
Aerogen Pharma Limited
INDUSTRY